(RMBS) Rambus - Overview
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 15.336m USD | Total Return: 159.7% in 12m
Avg Turnover: 279M
EPS Trend: 0.2%
Qual. Beats: 1
Rev. Trend: 96.4%
Qual. Beats: 0
Warnings
Volatile
Tailwinds
Tailwind, Pullback 52w
Rambus Inc. (RMBS) is a San Jose-based semiconductor company specializing in high-performance memory interface chips and silicon intellectual property (IP). The company’s hardware portfolio includes DDR5 and DDR4 interface components, power management integrated circuits (PMICs), and temperature sensors. Its IP division provides security and interface solutions designed for data centers, artificial intelligence, automotive systems, and government infrastructure.
The company operates a high-margin business model by licensing a vast portfolio of patents to original equipment manufacturers (OEMs), hyperscalers, and chipmakers. In the semiconductor industry, this fabless approach allows companies to generate recurring revenue through royalties and licensing fees without the heavy capital expenditure required for physical fabrication plants. As AI workloads increase demand for faster data processing, the transition from DDR4 to DDR5 architecture serves as a primary growth catalyst for memory interface suppliers.
For a deeper dive into the companys valuation metrics and historical performance, consider reviewing the comprehensive data available on ValueRay.
- DDR5 memory interface chip adoption accelerates within AI data center infrastructure
- Hyperscale server refresh cycles drive high-volume demand for memory interface products
- Silicon IP licensing revenue grows through advanced AI and automotive security applications
- Patent litigation outcomes and royalty rate negotiations impact long-term margin stability
- Global semiconductor supply chain fluctuations influence lead times for memory module partners
| Net Income: 230.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 4.95 > 1.0 |
| NWC/Revenue: 124.5% < 20% (prev 107.1%; Δ 17.40% < -1%) |
| CFO/TA 0.24 > 3% & CFO 365.8m > Net Income 230.0m |
| Net Debt (-762.7m) to EBITDA (302.3m): -2.52 < 3 |
| Current Ratio: 9.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (109.7m) vs 12m ago 1.00% < -2% |
| Gross Margin: 77.03% > 18% (prev 0.76%; Δ 7.63k% > 0.5%) |
| Asset Turnover: 49.52% > 50% (prev 43.89%; Δ 5.63% > 0%) |
| Interest Coverage Ratio: 203.0 > 6 (EBITDA TTM 302.3m / Interest Expense TTM 1.27m) |
| A: 0.59 (Total Current Assets 999.9m - Total Current Liabilities 101.8m) / Total Assets 1.53b |
| B: 0.09 (Retained Earnings 136.7m / Total Assets 1.53b) |
| C: 0.18 (EBIT TTM 258.8m / Avg Total Assets 1.46b) |
| D: 0.98 (Book Value of Equity 136.7m / Total Liabilities 139.9m) |
| Altman-Z'' = 6.35 = AAA |
| DSRI: 0.79 (Receivables 134.2m/142.8m, Revenue 721.2m/605.4m) |
| GMI: 0.98 (GM 77.03% / 75.87%) |
| AQI: 0.68 (AQ_t 0.27 / AQ_t-1 0.40) |
| SGI: 1.19 (Revenue 721.2m / 605.4m) |
| TATA: -0.09 (NI 230.0m - CFO 365.8m) / TA 1.53b) |
| Beneish M = -3.36 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 142.98 with a total of 1,568,819 shares traded.
Over the past week, the price has changed by +12.54%,
over one month by -9.73%,
over three months by +45.05% and
over the past year by +159.68%.
Rambus has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy RMBS.
- StrongBuy: 7
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 145.3 | 1.6% |
P/E Trailing = 67.5333
P/E Forward = 24.1546
P/S = 21.2659
P/B = 10.3593
P/EG = 3.8007
Revenue TTM = 721.2m USD
EBIT TTM = 258.8m USD
EBITDA TTM = 302.3m USD
Long Term Debt = 17.0m USD (estimated: total debt 23.4m - short term 6.36m)
Short Term Debt = 6.36m USD (from shortTermDebt, last quarter)
Debt = 23.4m USD (from shortLongTermDebtTotal, last quarter) (leases 23.4m already included)
Net Debt = -762.7m USD (calculated: Debt 23.4m - CCE 786.1m)
Enterprise Value = 14.6b USD (15.3b + Debt 23.4m - CCE 786.1m)
Interest Coverage Ratio = 203.0 (Ebit TTM 258.8m / Interest Expense TTM 1.27m)
EV/FCF = 43.48x (Enterprise Value 14.6b / FCF TTM 335.2m)
FCF Yield = 2.30% (FCF TTM 335.2m / Enterprise Value 14.6b)
FCF Margin = 46.48% (FCF TTM 335.2m / Revenue TTM 721.2m)
Net Margin = 31.89% (Net Income TTM 230.0m / Revenue TTM 721.2m)
Gross Margin = 77.03% ((Revenue TTM 721.2m - Cost of Revenue TTM 165.6m) / Revenue TTM)
Gross Margin QoQ = 79.73% (prev 78.86%)
Tobins Q-Ratio = 9.51 (Enterprise Value 14.6b / Total Assets 1.53b)
Interest Expense / Debt = 5.45% (Interest Expense 1.27m / Debt 23.4m)
Taxrate = 12.78% (8.77m / 68.6m)
NOPAT = 225.8m (EBIT 258.8m * (1 - 12.78%))
Current Ratio = 9.82 (Total Current Assets 999.9m / Total Current Liabilities 101.8m)
Debt / Equity = 0.02 (Debt 23.4m / totalStockholderEquity, last quarter 1.39b)
Debt / EBITDA = -2.52 (Net Debt -762.7m / EBITDA 302.3m)
Debt / FCF = -2.28 (Net Debt -762.7m / FCF TTM 335.2m)
Total Stockholder Equity = 1.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.79% (Net Income 230.0m / Total Assets 1.53b)
RoE = 17.44% (Net Income TTM 230.0m / Total Stockholder Equity 1.32b)
RoCE = 19.38% (EBIT 258.8m / Capital Employed (Equity 1.32b + L.T.Debt 17.0m))
RoIC = 15.86% (NOPAT 225.8m / Invested Capital 1.42b)
WACC = 15.54% (E(15.3b)/V(15.4b) * Re(15.56%) + D(23.4m)/V(15.4b) * Rd(5.45%) * (1-Tc(0.13)))
Discount Rate = 15.56% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -15.56 | Cagr: -0.14%
[DCF] Terminal Value 58.22% ; FCFF base≈294.5m ; Y1≈337.5m ; Y5≈496.8m
[DCF] Fair Price = 37.17 (EV 3.26b - Net Debt -762.7m = Equity 4.02b / Shares 108.1m; r=15.54% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 0.22 | EPS CAGR: 0.04% | SUE: 1.92 | # QB: 1
Revenue Correlation: 96.42 | Revenue CAGR: 21.17% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.72 | Chg30d=-0.51% | Revisions=+0% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.77 | Chg30d=-0.80% | Revisions=-17% | Analysts=8
EPS current Year (2026-12-31): EPS=2.93 | Chg30d=-0.64% | Revisions=-45% | GrowthEPS=+19.4% | GrowthRev=+15.9%
EPS next Year (2027-12-31): EPS=3.64 | Chg30d=+3.48% | Revisions=+27% | GrowthEPS=+23.9% | GrowthRev=+19.9%
[Analyst] Revisions Ratio: -45%